BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31689443)

  • 1. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.
    Ramasamy R; Mohammed F; Meier UC
    Immunol Lett; 2020 Jan; 217():15-24. PubMed ID: 31689443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
    Ramasamy R; Joseph B; Whittall T
    Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity between myelin oligodendrocyte glycoprotein and human endogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis.
    de Luca V; Martins Higa A; Malta Romano C; Pimenta Mambrini G; Peroni LA; Trivinho-Strixino F; Lima Leite F
    Micron; 2019 May; 120():66-73. PubMed ID: 30802755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico study of the association of the HLA-A*31:01 allele (human leucocyte antigen allele 31:01) with neuroantigenic epitopes of PLP (proteolipid protein), MBP (myelin basic protein) and MOG proteins (myelin oligodendrocyte glycoprotein) for studying the multiple sclerosis disease pathogenesis.
    Mohammadi-Milasi F; Mahnam K; Shakhsi-Niaei M
    J Biomol Struct Dyn; 2021 Apr; 39(7):2526-2542. PubMed ID: 32242486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.
    Mameli G; Poddighe L; Mei A; Uleri E; Sotgiu S; Serra C; Manetti R; Dolei A
    PLoS One; 2012; 7(9):e44991. PubMed ID: 23028727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501.
    de Rosbo NK; Kaye JF; Eisenstein M; Mendel I; Hoeftberger R; Lassmann H; Milo R; Ben-Nun A
    J Immunol; 2004 Jul; 173(2):1426-35. PubMed ID: 15240739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plausible contributor to multiple sclerosis; presentation of antigenic myelin protein epitopes by major histocompatibility complexes.
    Jakhmola S; Sk MF; Chatterjee A; Jain K; Kar P; Jha HC
    Comput Biol Med; 2022 Sep; 148():105856. PubMed ID: 35863244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
    Curtin F; Perron H; Kromminga A; Porchet H; Lang AB
    MAbs; 2015; 7(1):265-75. PubMed ID: 25427053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
    Arru G; Caggiu E; Leoni S; Mameli G; Pugliatti M; Sechi GP; Sechi LA
    J Neurol Sci; 2015 Oct; 357(1-2):106-8. PubMed ID: 26190523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.
    Tu X; Li S; Zhao L; Xiao R; Wang X; Zhu F
    Virol Sin; 2017 Aug; 32(4):280-289. PubMed ID: 28840564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.
    Derdelinckx J; Nkansah I; Ooms N; Van Bruggen L; Emonds MP; Daniëls L; Reynders T; Willekens B; Cras P; Berneman ZN; Cools N
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.